YTOT(300790)
Search documents
宇瞳光学(300790) - 关于2025年员工持股计划完成非交易过户的公告
2025-10-29 09:22
证券代码:300790 证券简称:宇瞳光学 公告编号:2025-073 东莞市宇瞳光学科技股份有限公司 关于2025年员工持股计划完成非交易过户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 东莞市宇瞳光学科技股份有限公司(以下简称"公司")于 2025 年 8 月 28 日召开 的第四届董事会第六次会议、第四届监事会第五次会议以及于 2025 年 9 月 15 日召开的 2025 年第二次临时股东大会审议通过了《关于 2025 年员工持股计划(草案)及摘要的 议案》等相关议案。根据《关于上市公司实施员工持股计划试点的指导意见》《深圳证 券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等有关法律、行 政法规、部门规章、规范性文件和深圳证券交易所的相关业务规则,现将公司 2025 年 员工持股计划(以下简称"本持股计划")实施进展情况公告如下: 一、本持股计划的股票来源及数量 (一)股票来源 (一)本持股计划的专户开立情况 截至本公告披露日,公司已在中国证券登记结算有限责任公司深圳分公司开立了本 持股计划专用证券账户,证券账户名称为"东 ...
机构风向标 | 宇瞳光学(300790)2025年三季度已披露前十大机构累计持仓占比10.55%
Xin Lang Cai Jing· 2025-10-29 02:14
Group 1 - The core viewpoint of the news is that Yutong Optical (300790.SZ) has seen a significant increase in institutional investor holdings, with a total of 31 institutions holding 43.64 million shares, representing 11.66% of the total share capital as of October 28, 2025 [1] - The top ten institutional investors collectively hold 10.55% of the shares, with their combined holding ratio increasing by 7.13 percentage points compared to the previous quarter [1] - The report highlights the involvement of various funds, including the Green Innovation Growth Mixed Fund, which has increased its holdings, and mentions 25 new public funds that have disclosed holdings in Yutong Optical [2] Group 2 - The news indicates that one new social security fund, the National Social Security Fund 501 Portfolio, has disclosed holdings in Yutong Optical [2] - Additionally, one foreign institution, Hong Kong Central Clearing Limited, has also disclosed its holdings in the company during this period [2]
宇瞳光学:2025年第三季度归属于上市公司股东的净利润同比增长64.91%
Zheng Quan Ri Bao· 2025-10-28 14:31
Core Insights - The company reported a revenue of 946,364,017.59 yuan for the third quarter of 2025, representing a year-on-year growth of 27.06% [2] - The net profit attributable to shareholders reached 80,397,189.09 yuan, showing a significant year-on-year increase of 64.91% [2] Financial Performance - Revenue for Q3 2025: 946.36 million yuan, up 27.06% year-on-year [2] - Net profit for Q3 2025: 80.40 million yuan, up 64.91% year-on-year [2]
宇瞳光学(300790.SZ)发布前三季度业绩,归母净利润1.88亿元,增长40.99%
智通财经网· 2025-10-28 11:54
Core Insights - The company reported a revenue of 2.362 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 18.49% [1] - The net profit attributable to shareholders reached 188 million yuan, showing a year-on-year increase of 40.99% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 186 million yuan, reflecting a year-on-year growth of 49.29% [1] - The basic earnings per share stood at 0.5 yuan [1]
宇瞳光学(300790) - 前次募集资金使用情况报告
2025-10-28 09:01
东莞市宇瞳光学科技股份有限公司 前次募集资金使用情况报告 根据中国证券监督管理委员会《监管规则适用指引——发行类第 7 号》的规定,东莞 市宇瞳光学科技股份有限公司(以下简称"宇瞳光学"或"本公司")编制了截至 2025 年 9 月 30 日的前次募集资金使用情况报告如下: 一、前次募集资金的募集及存放情况 (一)2020 年向特定对象发行股票募集资金情况 1、前次募集资金的数额、资金到账时间 经中国证券监督管理委员会出具的《关于同意东莞市宇瞳光学科技股份有限公司向特 定对象发行股票注册的批复》(证监许可【2020】3333 号),同意公司向特定对象发行 股票的注册申请。公司本次向特定对象发行股票 900 万股,发行价格为 16.13 元/股,募 集资金总额 145,170,000.00 元,扣除发行费用 4,811,320.74 元(不含税)后实际募集资 金净额为人民币 140,358,679.26 元。募集资金已于 2021 年 6 月 2 日划至公司指定账户。 上述资金到账情况已经华兴会计师事务所(特殊普通合伙)审验并出具的"华兴验字 【2021】21002100075 号"《验资报告》。公司与保荐机构 ...
宇瞳光学(300790) - 2025-072 第四届董事会第八次会议决议公告
2025-10-28 08:59
东莞市宇瞳光学科技股份有限公司(以下简称"公司")第四届董事会第八次会议于 2025 年 10 月 28 日在公司会议室以现场和通讯表决方式召开。会议通知于 2025 年 10 月 20 日以微信、电子邮件方式送达全体董事。本次会议由董事长张品光先生召集并主 持,应参加董事 9 名,实际参加董事 9 名,公司相关人员列席了会议。会议的召开和表 决程序符合《公司法》及《公司章程》的有关规定,合法有效。 二、董事会会议审议情况 证券代码:300790 证券简称:宇瞳光学 公告编号:2025-072 东莞市宇瞳光学科技股份有限公司 第四届董事会第八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 独立董事专门会议对本议案发表了明确同意的审查意见。 具体内容详见公司同日于巨潮资讯网(www.cninfo.com.cn)披露的《前次募集资 金使用情况报告》。 表决结果:赞成 9 票,反对 0 票,弃权 0 票,本议案获得通过。 三、备查文件 本次会议以记名投票方式进行表决并通过了如下决议: (一)审议通过《关于公司<2025 年第三 ...
宇瞳光学(300790) - 前次募集资金使用情况鉴证报告
2025-10-28 08:57
东莞市宇瞳光学科技股份有限公司 东莞市宇瞳光学科技股份有限公司全体股东: 我们接受委托,对后附的东莞市宇瞳光学科技股份有限公司(以下简称 "宇瞳光学")董事会编制的截至 2025 年 9 月 30 日的《前次募集资金使用情 况报告》执行了鉴证工作。 前次募集资金使用情况 鉴证报告 华兴专字[2025]24009370250 号 华兴会计师事务所(特殊普通合伙) 前次募集资金使用情况 鉴证报告 华兴专字[2025]24009370250号 一、董事会的责任 宇瞳光学董事会的责任是按照中国证券监督管理委员会《监管规则适用 指引——发行类第 7 号》的规定编制《前次募集资金使用情况报告》,并保证 其内容真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏。 二、注册会计师的责任 我们的责任是对宇瞳光学董事会编制的《前次募集资金使用情况报告》 发表鉴证结论。我们按照《中国注册会计师其他鉴证业务准则第 3101 号—— 历史财务信息审计或审阅以外的鉴证业务》的规定计划和实施鉴证工作,以 对上述《前次募集资金使用情况报告》是否不存在重大错报获取合理保证。 在鉴证工作中,我们结合宇瞳光学实际情况,实施了包括询问、检查会计 ...
宇瞳光学:10月28日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-10-28 08:52
Group 1 - Yutong Optical (SZ 300790) announced on October 28 that its fourth board meeting was held to review the proposal for the 2025 Q3 report [1] - For the first half of 2025, Yutong Optical's revenue composition was 93.94% from optical lens manufacturing and 6.06% from other businesses [1] - As of the report date, Yutong Optical's market capitalization was 11.5 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after ten years of stagnation, with a new "slow bull" market pattern emerging [1]
宇瞳光学(300790) - 2025 Q3 - 季度财报
2025-10-28 08:30
Financial Performance - The company's revenue for Q3 2025 reached ¥946,364,017.59, representing a 27.06% increase year-over-year[5] - Net profit attributable to shareholders was ¥80,397,189.09, a significant increase of 64.91% compared to the same period last year[5] - The basic earnings per share (EPS) for the period was ¥0.21, reflecting a 40.00% increase year-over-year[5] - Total operating revenue for the period reached ¥2,362,039,965.78, an increase of 18.4% compared to ¥1,993,437,970.18 in the previous period[21] - Operating profit for the current period was ¥208,291,405.05, representing a 33.9% increase from ¥155,474,812.06 in the previous period[21] - Net profit for the period totaled ¥202,390,574.48, compared to ¥153,245,353.83 in the last period, indicating a significant growth[21] - The net profit for the current period is $187.95 million, an increase of 27.8% compared to $147.09 million in the previous period[22] - The basic earnings per share for the current period is $0.50, up from $0.42 in the previous period, reflecting a growth of 19%[22] - The total comprehensive income for the current period is $188.54 million, compared to $147.28 million in the previous period, reflecting a growth of 27.9%[22] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥5,891,259,299.31, up 10.95% from the end of the previous year[5] - Total assets reached ¥5,891,259,299.31, up from ¥5,309,987,341.18, indicating a growth of 10.9%[20] - Total liabilities increased to ¥3,298,647,667.44 from ¥2,902,856,102.83, reflecting a rise of 13.7%[20] - The company’s total equity attributable to shareholders increased by 7.71% to ¥2,592,611,247.79 compared to the end of the previous year[5] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥280,870,609.71, an increase of 57.00%[5] - The net cash flow from operating activities is $280.87 million, an increase of 56.9% compared to $178.90 million in the previous period[25] - Cash flow from financing activities saw a 279.47% increase to $43,308,562.82, attributed to funds received from the employee stock ownership plan[13] - The net cash flow from investing activities is -$277.23 million, a decrease in outflow compared to -$188.83 million in the previous period[26] - The net cash flow from financing activities is $9.62 million, a decrease from $126.58 million in the previous period[26] Inventory and Receivables - Inventory increased by 34.23% to ¥778,659,302.34, primarily due to the preparation of new product materials[9] - Accounts receivable increased to ¥982,709,644.45 from ¥851,946,114.49, reflecting a growth of 15.3%[19] - Inventory levels rose to ¥778,659,302.34, compared to ¥580,077,026.24 at the start of the period, marking a 34.3% increase[19] Tax and Expenses - The company reported a 134.73% increase in income tax expenses, totaling ¥14,444,734.72, driven by higher total profits[11] - Tax refunds received increased significantly to $43,929,974.32, a 1254.04% rise compared to the previous period due to higher export tax rebates[13] - The company reported a tax expense of $14.44 million, compared to $6.15 million in the previous period, indicating a significant increase in tax obligations[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 30,683[14] - The largest shareholder, Zhang Pingguang, holds 11.01% of shares, totaling 41,176,041 shares, with 32,005,756 shares pledged[14] - The total number of restricted shares at the beginning of the period was 73,264,010, with 24,339,292 shares released from restrictions[16] Other Financial Metrics - Cash paid to employees rose by 48.13% to $324,101,053.62, primarily due to increased employee compensation[13] - Cash received from investment decreased by 81.39% to $115,000,000.00, mainly due to a reduction in the redemption of financial products[13] - Cash used for debt repayment increased by 80.56% to $1,131,407,080.67, reflecting higher bank loan repayments[13] - The net increase in cash and cash equivalents was $15,485,081.15, an 86.96% decrease compared to the previous period, primarily due to debt repayments[13] - Cash and cash equivalents at the end of the period were ¥560,344,208.56, up from ¥539,829,929.98 at the beginning of the period[19] - The cash and cash equivalents at the end of the period amount to $510.13 million, up from $490.74 million at the end of the previous period[26]
宇瞳光学:第三季度净利润8039.72万元,同比增长64.91%
Xin Lang Cai Jing· 2025-10-28 08:29
Core Insights - The company reported a third-quarter revenue of 946 million yuan, representing a year-on-year increase of 27.06% [1] - The net profit for the third quarter was 80.4 million yuan, showing a year-on-year growth of 64.91% [1] - For the first three quarters, the total revenue reached 2.362 billion yuan, up 18.49% compared to the same period last year [1] - The net profit for the first three quarters was 188 million yuan, reflecting a year-on-year increase of 40.99% [1]